Cellectar Biosciences Inc./$CLRB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Ticker
$CLRB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
11
ISIN
US15117F8077
Website
CLRB Metrics
BasicAdvanced
$17M
-
-$0.78
0.52
-
Price and volume
Market cap
$17M
Beta
0.52
52-week high
$0.69
52-week low
$0.23
Average daily volume
23M
Financial strength
Current ratio
2.474
Quick ratio
2.31
Long term debt to equity
4.008
Total debt to equity
4.923
Management effectiveness
Return on assets (TTM)
-97.91%
Return on equity (TTM)
-208.72%
Valuation
Price to book
2.15
Price to tangible book (TTM)
2.15
Price to free cash flow (TTM)
-0.337
Growth
Earnings per share change (TTM)
-79.01%
3-year earnings per share growth (CAGR)
-42.34%
CLRB News
AllArticlesVideos
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
GlobeNewsWire·4 days ago
Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)
GlobeNewsWire·5 days ago
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cellectar Biosciences Inc. stock?
Cellectar Biosciences Inc. (CLRB) has a market cap of $17M as of June 09, 2025.
What is the P/E ratio for Cellectar Biosciences Inc. stock?
The price to earnings (P/E) ratio for Cellectar Biosciences Inc. (CLRB) stock is 0 as of June 09, 2025.
Does Cellectar Biosciences Inc. stock pay dividends?
No, Cellectar Biosciences Inc. (CLRB) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Cellectar Biosciences Inc. dividend payment date?
Cellectar Biosciences Inc. (CLRB) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellectar Biosciences Inc.?
Cellectar Biosciences Inc. (CLRB) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.